Published in Schizophr Bull on November 17, 2011
The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry (2013) 4.16
Consistent etiology of severe, frequent psychotic experiences and milder, less frequent manifestations: a twin study of specific psychotic experiences in adolescence. JAMA Psychiatry (2014) 1.75
Specificity of childhood psychotic symptoms for predicting schizophrenia by 38 years of age: a birth cohort study. Psychol Med (2013) 1.34
Introduction: The extended psychosis phenotype--relationship with schizophrenia and with ultrahigh risk status for psychosis. Schizophr Bull (2012) 1.16
At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction. World Psychiatry (2015) 1.15
Prodromal psychosis detection in a counseling center population in China: an epidemiological and clinical study. Schizophr Res (2013) 1.06
Neurocognition in the extended psychosis phenotype: performance of a community sample of adolescents with psychotic symptoms on the MATRICS neurocognitive battery. Schizophr Bull (2012) 1.05
Age matters in the prevalence and clinical significance of ultra-high-risk for psychosis symptoms and criteria in the general population: Findings from the BEAR and BEARS-kid studies. World Psychiatry (2015) 1.00
Structural Brain Abnormalities in Youth With Psychosis Spectrum Symptoms. JAMA Psychiatry (2016) 0.94
Early detection and intervention of psychosis in children and adolescents: urgent need for studies. Eur Child Adolesc Psychiatry (2012) 0.94
Prevalence and clinical significance of DSM-5-attenuated psychosis syndrome in adolescents and young adults in the general population: the Bern Epidemiological At-Risk (BEAR) study. Schizophr Bull (2013) 0.92
Perinatal Risks and Childhood Premorbid Indicators of Later Psychosis: Next Steps for Early Psychosocial Interventions. Schizophr Bull (2015) 0.89
Chances and risks of predicting psychosis. Eur Arch Psychiatry Clin Neurosci (2012) 0.89
Towards a Standard Psychometric Diagnostic Interview for Subjects at Ultra High Risk of Psychosis: CAARMS versus SIPS. Psychiatry J (2016) 0.84
Frequency and pattern of childhood symptom onset reported by first episode schizophrenia and clinical high risk youth. Schizophr Res (2014) 0.81
Connectome-wide network analysis of youth with Psychosis-Spectrum symptoms. Mol Psychiatry (2015) 0.81
Relationship between the COMT-Val158Met and BDNF-Val66Met polymorphisms, childhood trauma and psychotic experiences in an adolescent general population sample. PLoS One (2013) 0.80
Identifying children and adolescents at ultra high risk of psychosis in Italian neuropsychiatry services: a feasibility study. Eur Child Adolesc Psychiatry (2015) 0.78
Anxiety in youth at clinical high risk for psychosis. Early Interv Psychiatry (2015) 0.77
Modelling psychosocial influences on the distress and impairment caused by psychotic-like experiences in children and adolescents. Eur Child Adolesc Psychiatry (2013) 0.77
Disturbances of the Basic Self and Prodromal Symptoms Among Young Adolescents From the Community: A Pilot Population-Based Study. Schizophr Bull (2016) 0.76
Functional Connectivity Anomalies in Adolescents with Psychotic Symptoms. PLoS One (2017) 0.75
Challenges in the early detection and intervention of the psychosis-risk syndrome. Shanghai Arch Psychiatry (2015) 0.75
Reduced P300 amplitude during retrieval on a spatial working memory task in a community sample of adolescents who report psychotic symptoms. BMC Psychiatry (2013) 0.75
Shared Etiology of Psychotic Experiences and Depressive Symptoms in Adolescence: A Longitudinal Twin Study. Schizophr Bull (2016) 0.75
A children's global assessment scale (CGAS). Arch Gen Psychiatry (1983) 12.78
Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry (2008) 9.54
Using the Strengths and Difficulties Questionnaire (SDQ) to screen for child psychiatric disorders in a community sample. Br J Psychiatry (2000) 7.18
A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med (2008) 5.61
Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch Gen Psychiatry (2000) 4.35
Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry (2002) 4.06
Psychotic symptoms in the general population - an evolutionary perspective. Br J Psychiatry (2010) 4.04
Prevalence and treatment of mental disorders among US children in the 2001-2004 NHANES. Pediatrics (2009) 3.98
Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry (2010) 3.88
Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr Res (2003) 3.86
At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry (2011) 3.66
North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull (2007) 3.28
Psychotic-like experiences in the general population: characterizing a high-risk group for psychosis. Psychol Med (2010) 3.00
Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull (2009) 2.90
Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull (1996) 2.87
The psychosis risk syndrome and its proposed inclusion in the DSM-V: a risk-benefit analysis. Schizophr Res (2010) 2.78
Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull (2007) 2.56
The initial prodrome in psychosis: descriptive and qualitative aspects. Aust N Z J Psychiatry (1996) 2.35
Prevalence of psychotic symptoms in childhood and adolescence: a systematic review and meta-analysis of population-based studies. Psychol Med (2012) 2.17
Should attenuated psychosis syndrome be a DSM-5 diagnosis? Am J Psychiatry (2011) 2.02
Pre-onset detection and intervention research in schizophrenia psychoses: current estimates of benefit and risk. Schizophr Bull (2001) 1.53
The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe. World Psychiatry (2005) 1.52
Are screening instruments valid for psychotic-like experiences? A validation study of screening questions for psychotic-like experiences using in-depth clinical interview. Schizophr Bull (2009) 1.49
Associations between childhood trauma, bullying and psychotic symptoms among a school-based adolescent sample. Br J Psychiatry (2008) 1.49
Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia. Schizophr Res (2004) 1.49
Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state. Schizophr Bull (2008) 1.44
Comorbid diagnoses in patients meeting criteria for the schizophrenia prodrome. Schizophr Res (2006) 1.38
Psychotic-like experiences in a community sample of adolescents: implications for the continuum model of psychosis and prediction of schizophrenia. Aust N Z J Psychiatry (2009) 1.31
Probably at-risk, but certainly ill--advocating the introduction of a psychosis spectrum disorder in DSM-V. Schizophr Res (2010) 1.26
The case for including Attenuated Psychotic Symptoms Syndrome in DSM-5 as a psychosis risk syndrome. Schizophr Res (2010) 1.14
Should a "Risk Syndrome for Psychosis" be included in the DSMV? Schizophr Res (2010) 1.11
Axis-I disorders and vulnerability to psychosis. Schizophr Res (2004) 1.05
Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Schizophr Res (2010) 0.98
Early detection of psychosis: finding those at clinical high risk. Early Interv Psychiatry (2008) 0.94
Risk syndromes, clinical staging and DSM V: new diagnostic infrastructure for early intervention in psychiatry. Schizophr Res (2010) 0.93
What percentage of people in the general population satisfies the current clinical at-risk criteria of psychosis? Schizophr Res (2010) 0.88
Valuing prodromal psychosis: what do we get and what is the price? Schizophr Res (2010) 0.86
Early self-experienced neuropsychological deficits and subsequent schizophrenic diseases: an 8-year average follow-up prospective study. Acta Psychiatr Scand (1997) 0.84
Perceived negative attitude of others predicts transition to psychosis in patients at risk of psychosis. Eur Psychiatry (2011) 0.81
Prodromal symptoms of schizophrenia in first-episode psychosis: prevalence and specificity. Compr Psychiatry (1995) 0.80
Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry (2004) 5.95
Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry (2005) 4.85
Psychotic symptoms in the general population - an evolutionary perspective. Br J Psychiatry (2010) 4.04
Clinicopathological significance of psychotic experiences in non-psychotic young people: evidence from four population-based studies. Br J Psychiatry (2012) 3.87
Childhood trauma and children's emerging psychotic symptoms: A genetically sensitive longitudinal cohort study. Am J Psychiatry (2010) 3.36
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ (2002) 3.06
Prevalence and correlates of self-reported psychotic symptoms in the British population. Br J Psychiatry (2004) 2.44
A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr Res (2004) 2.24
Evidence for an interaction between familial liability and prenatal exposure to infection in the causation of schizophrenia. Am J Psychiatry (2009) 2.21
Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. Am J Psychiatry (2013) 2.17
Etiological and clinical features of childhood psychotic symptoms: results from a birth cohort. Arch Gen Psychiatry (2010) 1.85
The prevalence of psychosis in epilepsy; a systematic review and meta-analysis. BMC Psychiatry (2014) 1.71
Psychotic symptoms and population risk for suicide attempt: a prospective cohort study. JAMA Psychiatry (2013) 1.69
Pathways to schizophrenia: the impact of environmental factors. Int J Neuropsychopharmacol (2004) 1.58
Are screening instruments valid for psychotic-like experiences? A validation study of screening questions for psychotic-like experiences using in-depth clinical interview. Schizophr Bull (2009) 1.49
Associations between childhood trauma, bullying and psychotic symptoms among a school-based adolescent sample. Br J Psychiatry (2008) 1.49
Premorbid intellectual functioning in bipolar disorder and schizophrenia: results from a cohort study of male conscripts. Am J Psychiatry (2005) 1.48
Rapidly progressive lung cysts and pleural effusion: a case report. Case Rep Pulmonol (2011) 1.39
Structural and functional brain correlates of subclinical psychotic symptoms in 11-13 year old schoolchildren. Neuroimage (2009) 1.38
The role of obstetric events in schizophrenia. Schizophr Bull (2005) 1.26
Childhood trauma and psychosis in a prospective cohort study: cause, effect, and directionality. Am J Psychiatry (2013) 1.25
Psychotic symptoms in adolescence index risk for suicidal behavior: findings from 2 population-based case-control clinical interview studies. Arch Gen Psychiatry (2012) 1.16
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull (2014) 1.10
Neurocognition in the extended psychosis phenotype: performance of a community sample of adolescents with psychotic symptoms on the MATRICS neurocognitive battery. Schizophr Bull (2012) 1.05
Towards a new paradigm of care: the International Declaration on Youth Mental Health. Early Interv Psychiatry (2013) 1.02
The validity of schizophrenia diagnosis in the Finnish Hospital Discharge Register: findings from a 10-year birth cohort sample. Nord J Psychiatry (2008) 1.01
Evidence for shared susceptibility to epilepsy and psychosis: a population-based family study. Biol Psychiatry (2012) 0.98
Language, motor and speed of processing deficits in adolescents with subclinical psychotic symptoms. Schizophr Res (2010) 0.98
Exposure to obstetric complications and subsequent development of bipolar disorder: Systematic review. Br J Psychiatry (2006) 0.96
An fMRI investigation of a novel analogue to the Trail-Making Test. Brain Cogn (2011) 0.94
Increased risk of schizophrenia from additive interaction between infant motor developmental delay and obstetric complications: evidence from a population-based longitudinal study. Am J Psychiatry (2011) 0.93
Chronic adolescent exposure to Δ-9-tetrahydrocannabinol in COMT mutant mice: impact on psychosis-related and other phenotypes. Neuropsychopharmacology (2010) 0.93
Is traumatic brain injury a risk factor for schizophrenia? A meta-analysis of case-controlled population-based studies. Schizophr Bull (2011) 0.93
Neurocognitive performance of a community-based sample of young people at putative ultra high risk for psychosis: support for the processing speed hypothesis. Cogn Neuropsychiatry (2012) 0.89
Neuroanatomical correlates of psychosis in temporal lobe epilepsy: voxel-based morphometry study. Br J Psychiatry (2010) 0.89
Childhood origins of violent behaviour in adults with schizophreniform disorder. Br J Psychiatry (2003) 0.89
Predicting risk and the emergence of schizophrenia. Psychiatr Clin North Am (2012) 0.87
Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways. Neuropsychopharmacology (2012) 0.84
Reduced duration mismatch negativity in adolescents with psychotic symptoms: further evidence for mismatch negativity as a possible biomarker for vulnerability to psychosis. BMC Psychiatry (2013) 0.84
The iceberg of suicide and self-harm in Irish adolescents: a population-based study. Soc Psychiatry Psychiatr Epidemiol (2014) 0.83
Whither the psychosis-neurosis borderline. Schizophr Bull (2014) 0.81
Foetal brain development in offspring of women with psychosis. Br J Psychiatry (2007) 0.81
Relationship between the COMT-Val158Met and BDNF-Val66Met polymorphisms, childhood trauma and psychotic experiences in an adolescent general population sample. PLoS One (2013) 0.80
Priming the brain for psychosis: maternal inflammation during fetal development and the risk of later psychiatric disorder. Am J Psychiatry (2014) 0.79
Language processing abnormalities in adolescents with psychotic-like experiences: an event related potential study. Schizophr Res (2012) 0.78
The impact of adolescent cannabis use, mood disorder and lack of education on attempted suicide in young adulthood. World Psychiatry (2014) 0.78
Psychotic symptoms, functioning and coping in adolescents with mental illness. BMC Psychiatry (2014) 0.77
Sudden death of father or sibling in early childhood increases risk for psychotic disorder. Schizophr Res (2012) 0.77
Maternal immune activation induces changes in myelin and metabolic proteins, some of which can be prevented with risperidone in adolescence. Dev Neurosci (2015) 0.76
Psychometric properties of the Revised Male Body Attitudes Scale among Irish men. Body Image (2010) 0.76
Reduced P300 amplitude during retrieval on a spatial working memory task in a community sample of adolescents who report psychotic symptoms. BMC Psychiatry (2013) 0.75
Authors' reply. Br J Psychiatry (2013) 0.75
Hearing voices--the significance of psychotic symptoms among young people. Rev Psiquiatr Salud Ment (2012) 0.75
Paternal age and mortality in nonaffective psychosis. Schizophr Res (2010) 0.75
Causal information on children's attitudes and behavioural intentions toward a peer with obesity. Obes Facts (2013) 0.75